Volume 26 Archives - Page 42 of 49 - IBO

Eppendorf Establishes New Subsidiary for Software

May 31, 2017/0 Comments/in Volume 26, Issue 4 Informatics, Mergers and Acquisitions Executive Briefing, M&A Executive Briefing Volume 26 /by admin

Company invests in SAAS solutions

Hitachi Takes Stake in Automated Genetics Company

May 31, 2017/0 Comments/in Volume 26, Issue 4 Life Science Instrumentation, Mergers and Acquisitions, Sample Preparation Executive Briefing, M&A Executive Briefing Volume 26 /by admin

Japanese firms combine capabilities

Lonza Invests in Exosomes

May 31, 2017/0 Comments/in Volume 26, Issue 4 Life Science Consumables, Mergers and Acquisitions Executive Briefing, M&A Executive Briefing Volume 26 /by Tanya Samazan

Lonza buys research tool company as cornerstone for expertise

Physicochemical Measurement Tool Providers Join Forces

May 31, 2017/0 Comments/in Volume 26, Issue 4 Lab Equipment, Materials Characterization, Mergers and Acquisitions Executive Briefing, M&A Executive Briefing Volume 26 /by admin

Pion adds to formulation testing business

Broad-Based Companies

May 31, 2017/0 Comments/in Volume 26, Issue 4 Corporate HR, Financial, Mergers and Acquisitions News Items Volume 26 /by admin

Company announcements

Sequencing

May 31, 2017/0 Comments/in Volume 26, Issue 4 Sequencing News Items Volume 26 /by admin

Company announcements, product introductions and sales/orders of note

Sample Preparation

May 31, 2017/0 Comments/in Volume 26, Issue 4 Sample Preparation News Items Volume 26 /by admin

Company announcements and product introductions

Materials Characterization

May 31, 2017/0 Comments/in Volume 26, Issue 4 Materials Characterization News Items Volume 26 /by admin

Company announcements and product introductions

IBO Sales Indexes Off to Strong Start: Industrial Market Lifts First Quarter Growth

May 31, 2017/0 Comments/in Volume 26, Issue 4 Financial Quarterly Summary Volume 26 /by admin

IBO Indexes on steady rise

Pharmaceuticals

May 31, 2017/0 Comments/in Volume 26, Issue 4 Pharmaceutical Industry Watch Volume 26 /by admin

Drug approvals on the fast track in 2017